The drug candidate, trevogrumab, in combination with Novo Nordisk's popular obesity drug Wegovy, chemically known as semaglutide, helped patients preserve muscle and increase fat loss in patients, ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

Oppenheimer initiated coverage of Western Union (NYSE:WU) with a Perform rating, citing competitive pressures and tightening U.S. immigration policy as key constraints on the company’s growth ...